• R&D
    • MDS
    • GMP & PIPELINE
  • PRODUCT
  • PUBLICATIONS
  • INVESTORS
    • 공시정보
    • 재무제표
    • 주가
    • IR정보
    • 공고
  • NEWS
  • PEOPLEBIO
KOREAN ENGLISH
KOREAN ENGLISH
  • R&D
    • MDS
    • GMP & PIPELINE
  • PRODUCT
  • PUBLICATIONS
  • INVESTORS
    • 공시정보
    • 재무제표
    • 주가
    • IR정보
    • 공고
  • NEWS
  • PEOPLEBIO

PUBLICATIONS

연구개발 중심의 피플바이오는 꾸준하게 논문을 발표하고 있습니다.

PUBLICATIONS

  • 2021
    Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
    RB. Mofrad, Philip Scheltens, Kim SY, Kang SM, Youn YC, An SSA, Jori Tomassen, Bart N. M. van Berckel, PJ.Visser, Wiesje M. van der Flier & Charlotte E. Teunissen
  • 2021
    Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins
    KY. Kulichikhin, SA. Fedotov, MS. Rubel, NM. Zalutskaya, AE. Zobnina, OA. Malikova, NG. Neznanov, YO. Chernoff & AA. Rubel
  • 2021
    Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
    Pyun JM, Ryu JS, Lee R, Shim KH, Youn YC, Ryoo NY, Han SW, Park YH, Kang SM, An SSA, Kim SY
  • 2021
    Is Korea Prepared for an Alzheimer’s Disease-Modifying Therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker Tests
    Jun HK, Cho SK, Yoong J, Mattke S
  • 2021
    Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer’s Disease
    Pyun JM, Kang MJ, Ryoo NY, Suh JW, Youn YC, Park YH, Kim SY
01 02 03 04 05
PeopleBio ⓒ 2020